Op-Ed: Printing bones in 3D- New synthetic bone scaffolding concept:
Washington State University researchers have used a 3-D printer to create a bone-like material and structure that can be used in orthopedic procedures, dental work and to deliver medicine for treating osteoporosis. Paired with actual bone, it acts as a scaffold for new bone to grow on and ultimately dissolves with no apparent ill effects.
Read more: http://www.digitaljournal.com/article/315340#ixzz1ffjClxft
Monday, December 5, 2011
Saturday, October 22, 2011
Osteopenia doesn't mean osteoporosis — so should you treat it? - latimes.com
The condition was recognized nearly 20 years ago by the World Health Organization as a potential precursor to osteoporosis, a severe thinning of the bones that can lead to increased risk of bone fracture. The idea was that women whose bones had started to thin could take action to reverse the trend before it was too late.
Osteopenia is identified by comparing a woman's bone density with that of a "young healthy adult" at peak bone density, around age 30.
The problem is, all women — and, to a lesser extent, men — begin to lose bone mass in midlife after the natural renewal process plateaus. In women, this accelerates after menopausebecause the loss of estrogen translates into less collagen for the bone matrix.
'via Blog this'
Menopausal and postmenopausal women's risks for many diseases increases, and sticking to a healthy diet is one natural preventive measure. Recent studies that analysed the diets of peri- and postmenopausal Spanish women found vitamin D deficiency common.
Read more: http://www.digitaljournal.com/article/313113#ixzz1bW0aXfua
Read more: http://www.digitaljournal.com/article/313113#ixzz1bW0aXfua
Study: Women don't get enough vitamin D during menopause
Read more: http://www.digitaljournal.com/article/313113#ixzz1bW0aXfua
'via Blog this'
Wednesday, September 21, 2011
New fat-derived stem cell treatment restores Lupus body functions
New fat-derived stem cell treatment restores Lupus body functions:
'via Blog this'
Those at risk for lupus
The Lupus Research Institute has found that those at risk for lupus are women of childbearing age, usually Asian, Latino, African-American and Native American descents. New organ damage is seen to occur more often in Afro-Caribbean patients and Asians.
The disease affects approximately 75 individuals out of one million, with no known cure. The mean age of patients in studies, such as the University College London, was 30 with a nine-year median follow-up.
This is why women’s issues are such a large factor, as there is a nine-to-one ratio of lupus that affects women over men. These issues consist of pregnancy, atherosclerosis and osteoporosis---in particular if the woman has been on steroids.
Read more: http://www.digitaljournal.com/article/311616#ixzz1YaiZa24M
'via Blog this'
Those at risk for lupus
The Lupus Research Institute has found that those at risk for lupus are women of childbearing age, usually Asian, Latino, African-American and Native American descents. New organ damage is seen to occur more often in Afro-Caribbean patients and Asians.
The disease affects approximately 75 individuals out of one million, with no known cure. The mean age of patients in studies, such as the University College London, was 30 with a nine-year median follow-up.
This is why women’s issues are such a large factor, as there is a nine-to-one ratio of lupus that affects women over men. These issues consist of pregnancy, atherosclerosis and osteoporosis---in particular if the woman has been on steroids.
Read more: http://www.digitaljournal.com/article/311616#ixzz1YaiZa24M
Tuesday, August 23, 2011
Actonel, Other Bone Drugs, May Lower Colon Cancer Risk: Study - AboutLawsuits.com
Actonel, Other Bone Drugs, May Lower Colon Cancer Risk: Study - AboutLawsuits.com: According to the findings of a new study, popular osteoporosis drugs, such as Actonel and Fosamax, may actually decrease the risk of colon cancer.
Canadian researchers say that women given the bisphosphonate drug Actonel were only half as likely to develop colorectal cancer as women who were not taking the medications or who had just started treatment. The findings were published online in the medical journal Cancer and come less than a month after the FDA warned that some of the bone drugs may be linked to an increased risk of esophageal cancer.
Researchers looked at the medical records of nearly 60,000 patients and found that those taking Actonel were 45% less likely to develop colorectal cancer. There was not enough data available to determine whether men received the same benefit and while researchers say that other bisphosphonates could also decrease colon cancer risk, the data they collected only showed a significant reduction of risk in those taking Actonel.
Actonel (risedronic acid) is an osteoporosis drug developed and marketed by Sanofi-Aventis and Warner Chilcott. It is approved for bone strengthening treatment and the prevention or treatment of osteoporosis and Paget’s disease.
Canadian researchers say that women given the bisphosphonate drug Actonel were only half as likely to develop colorectal cancer as women who were not taking the medications or who had just started treatment. The findings were published online in the medical journal Cancer and come less than a month after the FDA warned that some of the bone drugs may be linked to an increased risk of esophageal cancer.
Researchers looked at the medical records of nearly 60,000 patients and found that those taking Actonel were 45% less likely to develop colorectal cancer. There was not enough data available to determine whether men received the same benefit and while researchers say that other bisphosphonates could also decrease colon cancer risk, the data they collected only showed a significant reduction of risk in those taking Actonel.
Actonel (risedronic acid) is an osteoporosis drug developed and marketed by Sanofi-Aventis and Warner Chilcott. It is approved for bone strengthening treatment and the prevention or treatment of osteoporosis and Paget’s disease.
Osteoporosis Canada Releases White Paper On Canada’s Post Fracture Care Gap
Osteoporosis Canada - education and support for the risk-reduction and treatment of osteoporosis: On Monday, March 28th, 2011, Osteoporosis Canada released a white paper that assists health professionals and the public better understand the current post fracture care gap. The white paper, "Towards a Fracture-Free Future", addresses the need for appropriate assessment and treatment of patients with hip, spine and other osteoporotic fractures.
Referencing more than 50 scientific studies and reports, the white paper identifies the need for coordinated Post Fracture Care Programs with Case Managers to effectively identify and manage these patients.
Referencing more than 50 scientific studies and reports, the white paper identifies the need for coordinated Post Fracture Care Programs with Case Managers to effectively identify and manage these patients.
Prunes May Increase Bone Density in Postmenopausal Women » Naples Daily News
The researchers split 90 postmenopausal women into two groups. One group was given 100 grams of prunes, also known as dried plums, each day. The other group was given 100 grams of dried apples daily. The women were also given calcium and vitamin D supplements. At the conclusion of the year-long study, which was published in the British Journal of Nutrition, the women who ate prunes had a higher bone mineral density than their apple-eating counterparts. No other fruits tested in previous studies, including figs, dates, strawberries and raisins, had as positive an effect as prunes.
The researchers suggest that this may be happening because prunes suppress bone breakdown, which exceeds new bone growth rate in the elderly.
Subscribe to:
Posts (Atom)